Industry NBDF and WFH statement on severe adverse event with…Dec 22, 2025 Industry Trial Results for Investigational Glanzmann Thrombasthenia…Dec 12, 2025 Industry Five Year Hemgenix® Hemophilia B Trial Data Published in NEJMDec 10, 2025 Industry Interim Data for Investigational Sub-Q VWD Therapy Presented at ASHDec 9, 2025 Medical Women and Girls with Hemophilia Booklet Now Available in ArabicNov 17, 2025 Medical MASAC Approves Recommendations on Non-Factor Hemophilia…Nov 12, 2025 Industry BioMarin Announces ROCTAVIAN Out-Licensing Plans for Hemophilia A Therapy…Oct 31, 2025 Medical IHS Hosts New Webinar Series to Tackle Clinical Issues in Bleeding…Oct 14, 2025 Industry Star Therapeutics Announces New Financing for Investigational VWD…Oct 2, 2025 Industry Novo Submits New Application for Its Investigational SubQ Hemophilia…Sep 30, 2025 Industry New Approval Expands Indication for Recombinant VWD TherapySep 8, 2025 Medical FDA Approves Concizumab-mtci for Hemophilia Patients Without InhibitorsAug 14, 2025 Industry Be Biopharma Announces First Hemophilia Patient Dosed with New Cell…Jul 30, 2025 Industry New Trial Data Suggests Oral ITP Therapy Effective in Children and…Jul 25, 2025 Industry Pfizer Announces Phase 3 Trial Results for Hemophilia/Inhibitor TherapyJul 16, 2025 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page